Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer

par O I Kit, L Y Vladimirova, N A Abramova, A E Storozhakova, I L Popova, N M Tikhanovskaya, A A Lyaynova, L A Ryadinskaya
Publié 2017-06-01

Trastuzumab emtansine of the treatment of HER2-positive breast cancer with brain metatases

par L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, M. O. Ezhova, V. S. Myagkova, L. K. Strakhova
Publié 2020-12-01

Nab-paclitaxel monotherapy in patients with metastatic breast cancer with visceral crisis: evaluation of efficacy and tolerability in clinical practice

par L. Yu. Vladimirova, K. A. Novoselova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, L. A. Ryadinskaya, A. A. Lyanova, M. O. Ezhova, M. A. Teplyakova, A. A. Tishina, E. V. Prikhodko
Publié 2019-06-01

Fulvestrant in treatment for metastatic breast cancer

par L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, A. E. Storozhakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. L’yanova, L. A. Ryadinskaya, M. O. Ezhova, M. A. Teplyakova, L. K. Strakhov
Publié 2019-12-01

Survival of patients with metastatic bladder cancer in the Russian Federation: results of a multicenter registry study URRU

par I. V. Tsimafeyeu, G. N. Alekseeva, V. V. Petkau, R. A. Zukov, M. S. Mazhbich, A. V. Semenov, G. B. Statsenko, O. Yu. Novikova, I. V. Zaytsev, I. L. Popova, L. I. Gurina, M. A. Mukhina, L. Yu. Vladimirova
Publié 2021-11-01

Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy

par A. A. Lyanova, L. Yu. Vladimirova, E. P. Ulianova, A. E. Storozhakova, N. A. Abramova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, V. S. Myagkova, K. A. Novoselova, L. A. Ryadinskaya, L. K. Strakhova, E. A. Kalabanova
Publié 2020-07-01

Some aspects of nivolumab administration in treatment for metastatic melanoma (clinical cases)

par L. Yu. Vladimirova, A. Eh. Storozhakova, I. L. Popova, S. N. Kabanov, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, V. S. Myagkova, F. V. Alieva, E. A. Kalabanova, Ya. V. Svetitskaya, N. Yu. Samaneva, A. V. Tishina
Publié 2021-08-01

EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER

par O. I. Kit, L. Yu. Vladimirova, E. A. Kalabanova, A. E. Storozhakova, S. N. Kabanov, T. A. Snezhko, I. S. Mitashok, Ya. V. Svetitskaya, N. Yu. Samaneva, I. S. Kornilova, Yu. V. Przhedetskiy, V. V. Pozdnyakova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, A. A. Lyanova, K. A. Novoselova, L. A. Ryadinskaya
Publié 2021-05-01

Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II st...

par M. Yu. Fedyanin, L. Yu. Vladimirova, N. A. Abramova, A. E. Storozhakova, I. L. Popova, N. M. Tikhanovskaya, E. A. Kalabanova, Е. G. Panina, A. I. Arzamastseva, E. G. Rybakov, L. V. Bolotina, T. V. Ustinova, А. А. Kachmazov, I. A. Pokataev, A. A. Tryakin, O. V. Sekhina, D. A. Chekini, Kh. Kh.-M. Elsnukaeva, D. V. Podluzhniy, S. A. Tjulandin, O. I. Kit
Publié 2019-06-01

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study

par I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin
Publié 2019-12-01

Efficacy and toxicity of aflibercept and bevacizumab in combination with FOLFIRI in second‑line therapy for metastatic colon cancer: a retrospective multicenter study

par M.   Yu. Fedyanin, L.  Yu.  Vladimirova, V.  A.  Chubenko, L.   A. Zagorskaya, A.  V.  Belyaeva, O.  L.  Fakhrutdinova, S.  A.  Belukhin, A.   S. Zhabina, L.   V. Khalikova, L.  V.  Bolotina, R.   V. Orlova, F.  V.  Moiseenko, G.   Z. Mukhametshina, A.  I.  Khasanova, A.  V.  Belonogov, Kh.  S.  Musaeva, O.  Yu.  Novikova, I.  Yu.  Stradaeva, I.  L.  Popova, S.  P.  Erdniev, A.  K.  Ivanova, A.  V.  Androsova, P.  S.  Feoktistova, E.  S.  Kuzmina, E.   V. Karabina, O.  V.  Nekrasova, O.  V.  Sekhina, A.   A. Mishchenko, L.  A.  Mukova, B.  Kh.  Kertiev, G.  I.  Kosar, S.   N. Osodoeva, A.  I.  Kats, R.  R.  Malina, M.  A.  Lyadova, A.  A.  Tryakin, S.  A.  Tyulandin
Publié 2022-03-01

Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer

par M. Yu. Fedyanin, L. Yu. Vladimirova, V. A. Chubenko, L. A. Zagorskaya, A. V. Belyaeva, L. V. Bolotina, F. V. Moiseenko, O. L. Fakhrutdinova, S. A. Belukhin, A. S. Zhabina, L. V. Khalikova, V. M. Moiseenko, А. А. Meshcheryakov, E. V. Artamonova, I. A. Pokataev, A. I. Khasanova, A. V. Belonogov, Kh. S. Musaeva, O. Yu. Novikova, I. Yu. Stradaeva, I. L. Popova, G. Z. Mukhametshina, R. V. Orlova, S. P. Erdniev, A. K. Ivanova, A. V. Androsova, P. S. Feoktistova, E. S. Kuzmina, E. V. Karabina, O. V. Nekrasova, V. M. Sherstnev, A. A. Mishchenko, L. A. Mukova, B. Kh. Kertiev, G. I. Kosar, S. N. Osodoeva, A. I. Kats, R. R. Malina, A. A. Tryakin, S. A. Tjulandin
Publié 2019-06-01